Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marcin Nicoś
Observed names:
M Nicoś,
M. Nicoś,
MARCIN NICOŒ,
Marcin Nicos,
Nicos Marcin,
Nicoś, Marcin
show all 6
Institution:
Medical University of Lublin
Observed institutions:
Medical University of Lublin,
Medical University of Warsaw,
Science for Life Laboratory,
Karolinska Institutet,
Postgraduate School of Molecular Medicine
ORCID:
0000-0002-9566-113X
Observed ORCID:
0000-0002-9566-113X
OpenAlex ID:
A5079664149
Works
77
Awards
3
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection
2024
·
Natalia Galant
, Paweł Krawczyk
, et al.
·
International Journal of Molecular Sciences
·
136
PDF
Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas
2021
·
Luuk Harbers
, Federico Agostini
, et al.
·
Frontiers in Oncology
·
72
Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
2015
·
T. Powrózek
, P. Krawczyk
, et al.
·
Clinical & Translational Oncology
·
72
Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
2021
·
Justyna Błach
, Kamila Wojas-Krawczyk
, et al.
·
International Journal of Molecular Sciences
·
56
PDF
Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer
2022
·
Łukasz Rączkowski
, Iwona Paśnik
, et al.
·
BMC Cancer
·
52
PDF
The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
2013
·
Paweł Krawczyk
, Marcin Nicoś
, et al.
·
Pathology & Oncology Research
·
42
PDF
The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
2020
·
Marcin Nicoś
, Paweł Krawczyk
, et al.
·
Frontiers in Oncology
·
34
PDF
Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients
2019
·
Anna Grenda
, Justyna Błach
, et al.
·
Cancer Medicine
·
34
PDF
Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer
2022
·
Marcin Nicoś
, Paweł Krawczyk
·
Cancers
·
23
PDF
MicroRNAs aid the assessment of programmed death ligand�1 expression in patients with non‑small cell lung cancer
2019
·
Anna Grenda
, Marcin Nicoś
, et al.
·
Oncology Letters
·
23
PDF
Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients
2015
·
P. Krawczyk
, K. Reszka
, et al.
·
Annals of Oncology
·
23
PDF
Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients
2024
·
Natalia Galant
, Marcin Nicoś
, et al.
·
Cancers
·
22
PDF
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples
2019
·
Xiaolu Zhang
, Silvano Garnerone
, et al.
·
Nature Communications
·
20
PDF
The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer—A Preliminary Study
2021
·
Przemysław Kołodziej
, Marcin Nicoś
, et al.
·
International Journal of Molecular Sciences
·
19
PDF
Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients.
2019
·
M Szczyrek
, B Kuźnar-Kamińska
, et al.
·
PubMed
·
18
PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients
2019
·
Paweł Krawczyk
, Anna Grenda
, et al.
·
Cancer Genetics
·
16
Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study
2018
·
Kamila Wojas-Krawczyk
, Ewa Kalinka-Warzocha
, et al.
·
Advances in Clinical and Experimental Medicine
·
16
PDF
Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
2015
·
Marcin Nicoś
, Paweł Krawczyk
, et al.
·
Clinical and Experimental Medicine
·
16
PDF
Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients
2020
·
Marcin Nicoś
, Anna Rolska-Kopińska
, et al.
·
Archives of Medical Science
·
13
PDF
Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer
2012
·
Paweł Krawczyk
, Radosław Mlak
, et al.
·
Współczesna Onkologia
·
12
PDF
Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes
2017
·
Paweł Krawczyk
, Bożena Jarosz
, et al.
·
Oncotarget
·
11
The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
2022
·
Aleksandra Bożyk
, Marcin Nicoś
·
Life
·
10
PDF
Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer
2017
·
Marcin Nicoś
, Paweł Krawczyk
, et al.
·
Brain Tumor Pathology
·
10
PDF
Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer
2016
·
Marcin Nicoś
, Bożena Jarosz
, et al.
·
Brain Pathology
·
10
PIK3CA Mutations Detected in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer.
2016
·
Marcin Nicoś
, Paweł Krawczyk
, et al.
·
PubMed
·
10
Show more works
View as search
Works count:
77
Citation count:
888
H-index:
16
I10-index:
25
Year
Topic
Type